At a glance
- Originator Abbott Laboratories
- Class Antifungals; Antineoplastics; Piperidones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 29 Jan 2013 Discontinued - Preclinical for Mycoses in USA (unspecified route)
- 28 Sep 1998 No-Development-Reported for Mycoses in USA (unspecified route)
- 14 Jan 1997 Preclinical development for Mycoses in USA (unspecified route)